bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Down 19.1% in December

bioMérieux S.A. (OTCMKTS:BMXMF) saw a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 118,300 shares, a decrease of 19.1% from the December 15th total of 146,200 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 1,183.0 days.

bioMérieux Price Performance

bioMérieux stock remained flat at $110.92 during trading on Friday. The business’s 50 day simple moving average is $105.26 and its two-hundred day simple moving average is $108.71. bioMérieux has a fifty-two week low of $93.50 and a fifty-two week high of $122.52.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.